Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

207pages

Published Date: August 2012

Published By: GlobalData
Description


Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018


GlobalDatas new report, Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 provides key market data on the Orthobiologics market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within four market categories Bone Graft Substitutes, Bone Allografts, Viscosupplementation and Bone Growth Stimulators. The report also provides company shares and distribution shares data for the overall Orthobiologics market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the worlds most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or oldera population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. Its estimated that shortly after 2020, Indias population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

Scope

  • Market size data for Orthobiologics market categories Bone Graft Substitutes, Bone Allografts, Viscosupplementation and Bone Growth Stimulators. 
  • Annualized market revenues ($m), volume (units) and average price ($) data for each of the segments and sub-segments within the four market categories. Data from 2004 to 2011, forecast forward for seven years to 2018. 
  • 2011 company shares and distribution shares data for the overall Orthobiologics market in each of the aforementioned countries.
  • Global corporate-level profiles of key companies operating within the Orthobiologics market in BRICS.
  • Key players covered include DePuy, Inc., Genzyme Corporation, Synthes, Inc., Medtronic, Inc., Baxter International Inc., Biomet, Inc., Orthofix International N.V., Smith & Nephew Plc, Globus Medical, Inc., Wright Medical Group, Inc., Stryker Corporation, DJO Finance LLC, Ferring International Center S.A., Seikagaku Corporation, Anika Therapeutics, Inc. and Alphatec Holdings, Inc..

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Orthobiologics competitive landscape in BRICS.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.

 

 

Table of Contents

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 12

2 Introduction 15
2.1 What is This Report About? 15

3 Orthobiologics in BRICS 16
3.1 Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 16
3.2 Orthobiologics, BRICS, Company share (2010-2011) 21

4 Orthobiologics In Brazil 23
4.1 Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 23
4.2 Bone Graft Substitutes In Brazil 28
4.2.1 Bone Graft Substitutes, Brazil, Overall Revenue (2004-2018) 28
4.2.2 Bone Graft Substitutes, Brazil, Overall Volume (2004-2018) 32
4.2.3 Bone Graft Substitutes, Brazil, Average Price (2004-2018) 35
4.3 Bone Allografts In Brazil 36
4.3.1 Bone Allografts, Brazil, Overall Revenue (2004-2018) 36
4.4 Viscosupplementation In Brazil 38
4.4.1 Viscosupplementation, Brazil, Overall Revenue (2004-2018) 38
4.4.2 Viscosupplementation, Brazil, Overall Volume (2004-2018) 40
4.4.3 Viscosupplementation, Brazil, Average Price (2004-2018) 42
4.5 Bone Growth Stimulators In Brazil 43
4.5.1 Bone Growth Stimulators, Brazil, Overall Revenue (2004-2018) 43
4.5.2 Bone Growth Stimulators, Brazil, Overall Volume (2004-2018) 45
4.5.3 Bone Growth Stimulators, Brazil, Average Price (2004-2018) 47
4.6 Orthobiologics, Brazil, Distribution Share (2010-2011) 48
4.7 Orthobiologics, Brazil, Company Share (2010-2011) 49

5 Orthobiologics In Russian Federation 51
5.1 Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 51
5.2 Bone Graft Substitutes In Russian Federation 57
5.2.1 Bone Graft Substitutes, Russian Federation, Overall Revenue (2004-2018) 57
5.2.2 Bone Graft Substitutes, Russian Federation, Overall Volume (2004-2018) 61
5.2.3 Bone Graft Substitutes, Russian Federation, Average Price (2004-2018) 65
5.3 Bone Allografts In Russian Federation 66
5.3.1 Bone Allografts, Russian Federation, Overall Revenue (2004-2018) 66
5.4 Bone Growth Stimulators In Russian Federation 68
5.4.1 Bone Growth Stimulators, Russian Federation, Overall Revenue (2004-2018) 68
5.4.2 Bone Growth Stimulators, Russian Federation, Overall Volume (2004-2018) 71
5.4.3 Bone Growth Stimulators, Russian Federation, Average Price (2004-2018) 73
5.5 Viscosupplementation In Russian Federation 74
5.5.1 Viscosupplementation, Russian Federation, Overall Revenue (2004-2018) 74
5.5.2 Viscosupplementation, Russian Federation, Overall Volume (2004-2018) 77
5.5.3 Viscosupplementation, Russian Federation, Average Price (2004-2018) 79
5.6 Orthobiologics, Russian Federation, Distribution Share (2010-2011) 80
5.7 Orthobiologics, Russian Federation, Company Share (2010-2011) 81

6 Orthobiologics In India 83
6.1 Orthobiologics, India, Overall Revenue ($m), USD Constant, 2004-2018 83
6.2 Bone Graft Substitutes In India 88
6.2.1 Bone Graft Substitutes, India, Overall Revenue (2004-2018) 88
6.2.2 Bone Graft Substitutes, India, Overall Volume (2004-2018) 92
6.2.3 Bone Graft Substitutes, India, Average Price (2004-2018) 95
6.3 Bone Allografts In India 96
6.3.1 Bone Allografts, India, Overall Revenue (2004-2018) 96
6.4 Viscosupplementation In India 98
6.4.1 Viscosupplementation, India, Overall Revenue (2004-2018) 98
6.4.2 Viscosupplementation, India, Overall Volume (2004-2018) 100
6.4.3 Viscosupplementation, India, Average Price (2004-2018) 102
6.5 Bone Growth Stimulators In India 103
6.5.1 Bone Growth Stimulators, India, Overall Revenue (2004-2018) 103
6.5.2 Bone Growth Stimulators, India, Overall Volume (2004-2018) 105
6.5.3 Bone Growth Stimulators, India, Average Price (2004-2018) 107
6.6 Orthobiologics, India, Distribution Share (2010-2011) 108
6.7 Orthobiologics, India, Company Share (2010-2011) 109

7 Orthobiologics In China 111
7.1 Orthobiologics, China, Overall Revenue ($m), USD Constant, 2004-2018 111
7.2 Bone Graft Substitutes In China 116
7.2.1 Bone Graft Substitutes, China, Overall Revenue (2004-2018) 116
7.2.2 Bone Graft Substitutes, China, Overall Volume (2004-2018) 120
7.2.3 Bone Graft Substitutes, China, Average Price (2004-2018) 123
7.3 Bone Allografts In China 124
7.3.1 Bone Allografts, China, Overall Revenue (2004-2018) 124
7.4 Viscosupplementation In China 126
7.4.1 Viscosupplementation, China, Overall Revenue (2004-2018) 126
7.4.2 Viscosupplementation, China, Overall Volume (2004-2018) 128
7.4.3 Viscosupplementation, China, Average Price (2004-2018) 130
7.5 Bone Growth Stimulators In China 131
7.5.1 Bone Growth Stimulators, China, Overall Revenue (2004-2018) 131
7.5.2 Bone Growth Stimulators, China, Overall Volume (2004-2018) 133
7.5.3 Bone Growth Stimulators, China, Average Price (2004-2018) 135
7.6 Orthobiologics, China, Distribution Share (2010-2011) 136
7.7 Orthobiologics, China, Company Share (2010-2011) 137

8 Orthobiologics In South Africa 139
8.1 Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 139
8.2 Bone Graft Substitutes In South Africa 145
8.2.1 Bone Graft Substitutes, South Africa, Overall Revenue (2004-2018) 145
8.2.2 Bone Graft Substitutes, South Africa, Overall Volume (2004-2018) 149
8.2.3 Bone Graft Substitutes, South Africa, Average Price (2004-2018) 153
8.3 Bone Allografts In South Africa 154
8.3.1 Bone Allografts, South Africa, Overall Revenue (2004-2018) 154
8.4 Viscosupplementation In South Africa 156
8.4.1 Viscosupplementation, South Africa, Overall Revenue (2004-2018) 156
8.4.2 Viscosupplementation, South Africa, Overall Volume (2004-2018) 158
8.4.3 Viscosupplementation, South Africa, Average Price (2004-2018) 160
8.5 Bone Growth Stimulators In South Africa 161
8.5.1 Bone Growth Stimulators, South Africa, Overall Revenue (2004-2018) 161
8.5.2 Bone Growth Stimulators, South Africa, Overall Volume (2004-2018) 165
8.5.3 Bone Growth Stimulators, South Africa, Average Price (2004-2018) 167
8.6 Orthobiologics, South Africa, Distribution Share (2010-2011) 168
8.7 Orthobiologics, South Africa, Company Share (2010-2011) 169

9 Overview of Key Companies in BRICS Orthobiologics Market 171
9.1 DePuy, Inc. 171
9.1.1 Company Overview 171
9.1.2 Share in the BRICS Orthobiologics Market 172
9.2 Genzyme Corporation 173
9.2.1 Company Overview 173
9.2.2 Share in the BRICS Orthobiologics Market 174
9.3 Synthes, Inc. 175
9.3.1 Company Overview 175
9.3.2 Share in the BRICS Orthobiologics Market 176
9.4 Medtronic, Inc. 177
9.4.1 Company Overview 177
9.4.2 Share in the BRICS Orthobiologics Market 178
9.5 Baxter International Inc. 179
9.5.1 Company Overview 179
9.5.2 Share in the BRICS Orthobiologics Market 180
9.6 Biomet, Inc. 181
9.6.1 Company Overview 181
9.6.2 Share in the BRICS Orthobiologics Market 182
9.7 Orthofix International N.V. 183
9.7.1 Company Overview 183
9.7.2 Share in the BRICS Orthobiologics Market 184
9.8 Smith & Nephew Plc 185
9.8.1 Company Overview 185
9.8.2 Share in the BRICS Orthobiologics Market 186
9.9 Globus Medical, Inc. 187
9.9.1 Company Overview 187
9.10 Wright Medical Group, Inc. 188
9.10.1 Company Overview 188
9.10.2 Share in the BRICS Orthobiologics Market 189
9.11 Stryker Corporation 190
9.11.1 Company Overview 190
9.11.2 Share in the BRICS Orthobiologics Market 191
9.12 DJO Finance LLC 192
9.12.1 Company Overview 192
9.12.2 Share in the BRICS Orthobiologics Market 193
9.13 Ferring International Center S.A. 194
9.13.1 Company Overview 194
9.13.2 Share in the BRICS Orthobiologics Market 195
9.14 Seikagaku Corporation 196
9.14.1 Company Overview 196
9.15 Anika Therapeutics, Inc. 197
9.15.1 Company Overview 197
9.15.2 Share in the BRICS Orthobiologics Market 198
9.16 Alphatec Holdings, Inc. 199
9.16.1 Company Overview 199
9.16.2 Share in the BRICS Orthobiologics Market 200
9.17 NuVasive, Inc. 201
9.17.1 Company Overview 201

10 Appendix 202
10.1 Definitions of Markets Covered in the Report 203
10.1.1 Orthobiologics 203
10.2 Research Methodology 204
10.3 Secondary Research 204
10.4 Primary Research 205
10.5 Models 205
10.6 Forecasts 206
10.7 Expert Panels 206
10.8 GlobalData Consulting 206
10.9 Currency Conversion 207
10.10 Contact Us 207
10.11 Disclaimer 207


List Of Figures


Figure 1: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 16
Figure 2: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011 17
Figure 3: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 19
Figure 4: Orthobiologics, BRICS, Company share (%), 2011 21
Figure 5: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 23
Figure 6: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 24
Figure 7: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 26
Figure 8: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 28
Figure 9: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 30
Figure 10: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Historic, 2004-2011 32
Figure 11: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Forecast, 2011-2018 34
Figure 12: Bone Allografts, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 36
Figure 13: Bone Allografts, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 37
Figure 14: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 38
Figure 15: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 39
Figure 16: Viscosupplementation, Brazil, Volume (Units), Historic, 2004-2011 40
Figure 17: Viscosupplementation, Brazil, Volume (Units), Forecast, 2011-2018 41
Figure 18: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 43
Figure 19: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 44
Figure 20: Bone Growth Stimulators, Brazil, Volume (Units), Historic, 2004-2011 45
Figure 21: Bone Growth Stimulators, Brazil, Volume (Units), Forecast, 2011-2018 46
Figure 22: Orthobiologics, Brazil, Company Share (%), 2011 49
Figure 23: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 51
Figure 24: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011 53
Figure 25: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 55
Figure 26: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 57
Figure 27: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 59
Figure 28: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Historic, 2004-2011 61
Figure 29: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Forecast, 2011-2018 63
Figure 30: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 66
Figure 31: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 67
Figure 32: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 68
Figure 33: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 70
Figure 34: Bone Growth Stimulators, Russian Federation, Volume (Units), Historic, 2004-2011 71
Figure 35: Bone Growth Stimulators, Russian Federation, Volume (Units), Forecast, 2011-2018 72
Figure 36: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 74
Figure 37: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 76
Figure 38: Viscosupplementation, Russian Federation, Volume (Units), Historic, 2004-2011 77
Figure 39: Viscosupplementation, Russian Federation, Volume (Units), Forecast, 2011-2018 78
Figure 40: Orthobiologics, Russian Federation, Company Share (%), 2011 81
Figure 41: Orthobiologics, India, Overall Revenue ($m), USD Constant, 2004-2018 83
Figure 42: Orthobiologics, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 84
Figure 43: Orthobiologics, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 86
Figure 44: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 88
Figure 45: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 90
Figure 46: Bone Graft Substitutes, India, Volume (Units) by Segment, Historic, 2004-2011 92
Figure 47: Bone Graft Substitutes, India, Volume (Units) by Segment, Forecast, 2011-2018 94
Figure 48: Bone Allografts, India, Revenue ($m), USD Constant, Historic, 2004-2011 96
Figure 49: Bone Allografts, India, Revenue ($m), USD Constant, Forecast, 2011-2018 97
Figure 50: Viscosupplementation, India, Revenue ($m), USD Constant, Historic, 2004-2011 98
Figure 51: Viscosupplementation, India, Revenue ($m), USD Constant, Forecast, 2011-2018 99
Figure 52: Viscosupplementation, India, Volume (Units), Historic, 2004-2011 100
Figure 53: Viscosupplementation, India, Volume (Units), Forecast, 2011-2018 101
Figure 54: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Historic, 2004-2011 103
Figure 55: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Forecast, 2011-2018 104
Figure 56: Bone Growth Stimulators, India, Volume (Units), Historic, 2004-2011 105
Figure 57: Bone Growth Stimulators, India, Volume (Units), Forecast, 2011-2018 106
Figure 58: Orthobiologics, India, Company Share (%), 2011 109
Figure 59: Orthobiologics, China, Overall Revenue ($m), USD Constant, 2004-2018 111
Figure 60: Orthobiologics, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 112
Figure 61: Orthobiologics, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 114
Figure 62: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 116
Figure 63: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 118
Figure 64: Bone Graft Substitutes, China, Volume (Units) by Segment, Historic, 2004-2011 120
Figure 65: Bone Graft Substitutes, China, Volume (Units) by Segment, Forecast, 2011-2018 122
Figure 66: Bone Allografts, China, Revenue ($m), USD Constant, Historic, 2004-2011 124
Figure 67: Bone Allografts, China, Revenue ($m), USD Constant, Forecast, 2011-2018 125
Figure 68: Viscosupplementation, China, Revenue ($m), USD Constant, Historic, 2004-2011 126
Figure 69: Viscosupplementation, China, Revenue ($m), USD Constant, Forecast, 2011-2018 127
Figure 70: Viscosupplementation, China, Volume (Units), Historic, 2004-2011 128
Figure 71: Viscosupplementation, China, Volume (Units), Forecast, 2011-2018 129
Figure 72: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Historic, 2004-2011 131
Figure 73: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Forecast, 2011-2018 132
Figure 74: Bone Growth Stimulators, China, Volume (Units), Historic, 2004-2011 133
Figure 75: Bone Growth Stimulators, China, Volume (Units), Forecast, 2011-2018 134
Figure 76: Orthobiologics, China, Company Share (%), 2011 137
Figure 77: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 139
Figure 78: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 141
Figure 79: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 143
Figure 80: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 145
Figure 81: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 147
Figure 82: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Historic, 2004-2011 149
Figure 83: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Forecast, 2011-2018 151
Figure 84: Bone Allografts, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 154
Figure 85: Bone Allografts, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 155
Figure 86: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 156
Figure 87: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 157
Figure 88: Viscosupplementation, South Africa, Volume (Units), Historic, 2004-2011 158
Figure 89: Viscosupplementation, South Africa, Volume (Units), Forecast, 2011-2018 159
Figure 90: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 161
Figure 91: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 163
Figure 92: Bone Growth Stimulators, South Africa, Volume (Units), Historic, 2004-2011 165
Figure 93: Bone Growth Stimulators, South Africa, Volume (Units), Forecast, 2011-2018 166
Figure 94: Orthobiologics, South Africa, Company Share (%), 2011 169
Figure 95: DePuy, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 172
Figure 96: Genzyme Corporation, Company Share (%), BRICS Orthobiologics Market, 2011 174
Figure 97: Synthes, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 176
Figure 98: Medtronic, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 178
Figure 99: Baxter International Inc., Company Share (%), BRICS Orthobiologics Market, 2011 180
Figure 100: Biomet, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 182
Figure 101: Orthofix International N.V., Company Share (%), BRICS Orthobiologics Market, 2011 184
Figure 102: Smith & Nephew Plc, Company Share (%), BRICS Orthobiologics Market, 2011 186
Figure 103: Wright Medical Group, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 189
Figure 104: Stryker Corporation, Company Share (%), BRICS Orthobiologics Market, 2011 191
Figure 105: DJO Finance LLC, Company Share (%), BRICS Orthobiologics Market, 2011 193
Figure 106: Ferring International Center S.A., Company Share (%), BRICS Orthobiologics Market, 2011 195
Figure 107: Anika Therapeutics, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 198
Figure 108: Alphatec Holdings, Inc., Company Share (%), BRICS Orthobiologics Market, 2011 200


List Of Tables


Table 1: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 16
Table 2: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011 18
Table 3: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 20
Table 4: Orthobiologics, BRICS, Company share by Revenue ($m), USD Constant, 2010-2011 22
Table 5: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 23
Table 6: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 25
Table 7: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 27
Table 8: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 29
Table 9: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 31
Table 10: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Historic, 2004-2011 33
Table 11: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Forecast, 2011-2018 34
Table 12: Bone Graft Substitutes, Brazil, Average Price ($), Historic, 2004-2011 35
Table 13: Bone Graft Substitutes, Brazil, Average Price ($), Forecast, 2011-2018 35
Table 14: Bone Allografts, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 36
Table 15: Bone Allografts, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 37
Table 16: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 38
Table 17: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 39
Table 18: Viscosupplementation, Brazil, Volume (Units), Historic, 2004-2011 40
Table 19: Viscosupplementation, Brazil, Volume (Units), Forecast, 2011-2018 41
Table 20: Viscosupplementation, Brazil, Average Price ($), Historic, 2004-2011 42
Table 21: Viscosupplementation, Brazil, Average Price ($), Forecast, 2011-2018 42
Table 22: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 43
Table 23: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 44
Table 24: Bone Growth Stimulators, Brazil, Volume (Units), Historic, 2004-2011 45
Table 25: Bone Growth Stimulators, Brazil, Volume (Units), Forecast, 2011-2018 46
Table 26: Bone Growth Stimulators, Brazil, Average Price ($), Historic, 2004-2011 47
Table 27: Bone Growth Stimulators, Brazil, Average Price ($), Forecast, 2011-2018 47
Table 28: Orthobiologics, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 48
Table 29: Orthobiologics, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 50
Table 30: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 52
Table 31: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011 54
Table 32: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 56
Table 33: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 58
Table 34: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 60
Table 35: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Historic, 2004-2011 62
Table 36: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Forecast, 2011-2018 64
Table 37: Bone Graft Substitutes, Russian Federation, Average Price ($), Historic, 2004-2011 65
Table 38: Bone Graft Substitutes, Russian Federation, Average Price ($), Forecast, 2011-2018 65
Table 39: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 66
Table 40: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 67
Table 41: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 69
Table 42: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 70
Table 43: Bone Growth Stimulators, Russian Federation, Volume (Units), Historic, 2004-2011 71
Table 44: Bone Growth Stimulators, Russian Federation, Volume (Units), Forecast, 2011-2018 72
Table 45: Bone Growth Stimulators, Russian Federation, Average Price ($), Historic, 2004-2011 73
Table 46: Bone Growth Stimulators, Russian Federation, Average Price ($), Forecast, 2011-2018 73
Table 47: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 75
Table 48: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 76
Table 49: Viscosupplementation, Russian Federation, Volume (Units), Historic, 2004-2011 77
Table 50: Viscosupplementation, Russian Federation, Volume (Units), Forecast, 2011-2018 78
Table 51: Viscosupplementation, Russian Federation, Average Price ($), Historic, 2004-2011 79
Table 52: Viscosupplementation, Russian Federation, Average Price ($), Forecast, 2011-2018 79
Table 53: Orthobiologics, Russian Federation, Distribution Share by Revenue ($m), USD Constant, 2010-2011 80
Table 54: Orthobiologics, Russian Federation, Company Share by Revenue ($m), USD Constant, 2010-2011 82
Table 55: Orthobiologics, India, Overall Revenue ($m), USD Constant, 2004-2018 83
Table 56: Orthobiologics, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 85
Table 57: Orthobiologics, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 87
Table 58: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 89
Table 59: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 91
Table 60: Bone Graft Substitutes, India, Volume (Units) by Segment, Historic, 2004-2011 93
Table 61: Bone Graft Substitutes, India, Volume (Units) by Segment, Forecast, 2011-2018 94
Table 62: Bone Graft Substitutes, India, Average Price ($), Historic, 2004-2011 95
Table 63: Bone Graft Substitutes, India, Average Price ($), Forecast, 2011-2018 95
Table 64: Bone Allografts, India, Revenue ($m), USD Constant, Historic, 2004-2011 96
Table 65: Bone Allografts, India, Revenue ($m), USD Constant, Forecast, 2011-2018 97
Table 66: Viscosupplementation, India, Revenue ($m), USD Constant, Historic, 2004-2011 98
Table 67: Viscosupplementation, India, Revenue ($m), USD Constant, Forecast, 2011-2018 99
Table 68: Viscosupplementation, India, Volume (Units), Historic, 2004-2011 100
Table 69: Viscosupplementation, India, Volume (Units), Forecast, 2011-2018 101
Table 70: Viscosupplementation, India, Average Price ($), Historic, 2004-2011 102
Table 71: Viscosupplementation, India, Average Price ($), Forecast, 2011-2018 102
Table 72: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Historic, 2004-2011 103
Table 73: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Forecast, 2011-2018 104
Table 74: Bone Growth Stimulators, India, Volume (Units), Historic, 2004-2011 105
Table 75: Bone Growth Stimulators, India, Volume (Units), Forecast, 2011-2018 106
Table 76: Bone Growth Stimulators, India, Average Price ($), Historic, 2004-2011 107
Table 77: Bone Growth Stimulators, India, Average Price ($), Forecast, 2011-2018 107
Table 78: Orthobiologics, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 108
Table 79: Orthobiologics, India, Company Share by Revenue ($m), USD Constant, 2010-2011 110
Table 80: Orthobiologics, China, Overall Revenue ($m), USD Constant, 2004-2018 111
Table 81: Orthobiologics, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 113
Table 82: Orthobiologics, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 115
Table 83: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 117
Table 84: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 119
Table 85: Bone Graft Substitutes, China, Volume (Units) by Segment, Historic, 2004-2011 121
Table 86: Bone Graft Substitutes, China, Volume (Units) by Segment, Forecast, 2011-2018 122
Table 87: Bone Graft Substitutes, China, Average Price ($), Historic, 2004-2011 123
Table 88: Bone Graft Substitutes, China, Average Price ($), Forecast, 2011-2018 123
Table 89: Bone Allografts, China, Revenue ($m), USD Constant, Historic, 2004-2011 124
Table 90: Bone Allografts, China, Revenue ($m), USD Constant, Forecast, 2011-2018 125
Table 91: Viscosupplementation, China, Revenue ($m), USD Constant, Historic, 2004-2011 126
Table 92: Viscosupplementation, China, Revenue ($m), USD Constant, Forecast, 2011-2018 127
Table 93: Viscosupplementation, China, Volume (Units), Historic, 2004-2011 128
Table 94: Viscosupplementation, China, Volume (Units), Forecast, 2011-2018 129
Table 95: Viscosupplementation, China, Average Price ($), Historic, 2004-2011 130
Table 96: Viscosupplementation, China, Average Price ($), Forecast, 2011-2018 130
Table 97: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Historic, 2004-2011 131
Table 98: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Forecast, 2011-2018 132
Table 99: Bone Growth Stimulators, China, Volume (Units), Historic, 2004-2011 133
Table 100: Bone Growth Stimulators, China, Volume (Units), Forecast, 2011-2018 134
Table 101: Bone Growth Stimulators, China, Average Price ($), Historic, 2004-2011 135
Table 102: Bone Growth Stimulators, China, Average Price ($), Forecast, 2011-2018 135
Table 103: Orthobiologics, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 136
Table 104: Orthobiologics, China, Company Share by Revenue ($m), USD Constant, 2010-2011 138
Table 105: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 140
Table 106: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 142
Table 107: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 144
Table 108: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 146
Table 109: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 148
Table 110: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Historic, 2004-2011 150
Table 111: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Forecast, 2011-2018 152
Table 112: Bone Graft Substitutes, South Africa, Average Price ($), Historic, 2004-2011 153
Table 113: Bone Graft Substitutes, South Africa, Average Price ($), Forecast, 2011-2018 153
Table 114: Bone Allografts, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 154
Table 115: Bone Allografts, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 155
Table 116: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 156
Table 117: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 157
Table 118: Viscosupplementation, South Africa, Volume (Units), Historic, 2004-2011 158
Table 119: Viscosupplementation, South Africa, Volume (Units), Forecast, 2011-2018 159
Table 120: Viscosupplementation, South Africa, Average Price ($), Historic, 2004-2011 160
Table 121: Viscosupplementation, South Africa, Average Price ($), Forecast, 2011-2018 160
Table 122: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 162
Table 123: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 164
Table 124: Bone Growth Stimulators, South Africa, Volume (Units), Historic, 2004-2011 165
Table 125: Bone Growth Stimulators, South Africa, Volume (Units), Forecast, 2011-2018 166
Table 126: Bone Growth Stimulators, South Africa, Average Price ($), Historic, 2004-2011 167
Table 127: Bone Growth Stimulators, South Africa, Average Price ($), Forecast, 2011-2018 167
Table 128: Orthobiologics, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011 168
Table 129: Orthobiologics, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 170
Table 130: DePuy, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 172
Table 131: Genzyme Corporation, Revenue ($m), BRICS Orthobiologics Market, 2011 174
Table 132: Synthes, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 176
Table 133: Medtronic, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 178
Table 134: Baxter International Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 180
Table 135: Biomet, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 182
Table 136: Orthofix International N.V., Revenue ($m), BRICS Orthobiologics Market, 2011 184
Table 137: Smith & Nephew Plc, Revenue ($m), BRICS Orthobiologics Market, 2011 186
Table 138: Globus Medical, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 187
Table 139: Wright Medical Group, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 189
Table 140: Stryker Corporation, Revenue ($m), BRICS Orthobiologics Market, 2011 191
Table 141: DJO Finance LLC, Revenue ($m), BRICS Orthobiologics Market, 2011 193
Table 142: Ferring International Center S.A., Revenue ($m), BRICS Orthobiologics Market, 2011 195
Table 143: Seikagaku Corporation, Revenue ($m), BRICS Orthobiologics Market, 2011 196
Table 144: Anika Therapeutics, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 198
Table 145: Alphatec Holdings, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011 200

More Reports in





» China Cystoscopes Market Outlook to 2020

China Cystoscopes Market Outlook to 2020 Summary GlobalDatas new report, "China Cystoscopes Market Outlook to 2020", provides key market data on the China Cystoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Flexible Video Cystoscopes and Non-Vid...


» China Surgical Generators Market Outlook to 2020

China Surgical Generators Market Outlook to 2020 Summary GlobalDatas new report, "China Surgical Generators Market Outlook to 2020", provides key market data on the China Surgical Generators market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Electrosurgica...


» China Ureteroscopes Market Outlook to 2020

GlobalDatas new report, "China Ureteroscopes Market Outlook to 2020", provides key market data on the China Ureteroscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments Flexible Video Ureteroscopes and Non-Video Ureteroscopes (Semi-Rigid Non-Video Ur...


» China Sinuscopes Market Outlook to 2020

GlobalDatas new report, "China Sinuscopes Market Outlook to 2020", provides key market data on the China Sinuscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments Rigid Non-Video Sinuscopes. The report also provides company shares and distrib...


» China Endoscopy Visualization Systems Market Outlook to 2020

GlobalDatas new report, "China Endoscopy Visualization Systems Market Outlook to 2020", provides key market data on the China Endoscopy Visualization Systems market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments High-End Endoscopy Visualization Systems, Mid...


» Capacity and Capital Expenditure Outlook for Refineries in Asia and Oceania - China Drives Refinery Capacity Growth

GlobalDatas energy offering, Capacity and Capital Expenditure Outlook for Refineries in Asia and Oceania China Drives Refinery Capacity Growth is the essential source for industry data and information relating to the refining industry in Asia and Oceania. It provides asset level information relating to active and planned refineries in Asia...


» China Laryngoscopes Market Outlook to 2020

GlobalDatas new report, "China Laryngoscopes Market Outlook to 2020", provides key market data on the China Laryngoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments Video Laryngoscopes (Flexible Video Laryngoscopes and Portable Video Laryngoscope...


» China Colonoscopes Market Outlook to 2020

China Colonoscopes Market Outlook to 2020 Summary GlobalDatas new report, "China Colonoscopes Market Outlook to 2020", provides key market data on the China Colonoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Flexible Video Colonoscopes and Fle...


» China Duodenoscopes Market Outlook to 2020

China Duodenoscopes Market Outlook to 2020 Summary GlobalDatas new report, "China Duodenoscopes Market Outlook to 2020", provides key market data on the China Duodenoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Flexible Video Duodenoscopes and...


» China Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations and Competitive Landscape

China Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations and Competitive Landscape Summary This report elaborates Chinas power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the China power markets regulatory structure, import and expor...



Related News

News Aug 24, 2012

Chinese Firm taps at Rockville Biotech for Vaccine Technology

A Chinese company is being tapped by the drug manufacturer Rockville Biotech Fina Solutions for vaccine technology. Rockville Biotech is licensing the firm to manufacture pneumonia vaccine by using its developed technology. Rockville Biot...

News Aug 24, 2012

China Telecom Giant Unicom Beats Expectations, Posts High Profits On 3G Services

The second largest mobile phone company of China, China Unicom Limited, posted high profit margins for the recently concluded half year and is expected to rise further with growth driving on increased number of 3G services subscribers. Th...

News Aug 25, 2012

Global Medical Simulation Market

Medical simulation is a training method used to train different processes and tasks to medical professionalsin life like circumstances. Theprocess requires several tools or equipment which includes models, actor-patients, peers, surveillance and ...








All Rights Reserved   Latest News   Latest Reports